Lai, Jianguo
Deng, Shuxuan
Cao, Jiyuan
Ren, Yongqi
Xu, Zanmei
Qi, Xiaofang
Xu, Mian
Liao, Ning
Funding for this research was provided by:
National Natural Science Foundation of China (82372601)
Guangdong Medical Research Foundation (A2023035)
Guangzhou Municipal Science and Technology Project (202201011184)
National Key Clinical Specialty Construction Project (2022YW030009)
China Anti-Cancer Association-HER2 Target China Scientific Research Fund (CORP-239-S24)
Article History
Received: 3 March 2024
Accepted: 22 August 2024
First Online: 6 September 2024
Declarations
:
: All methods were carried out in accordance with the Declaration of Helsinki and Ethics regulations of the GDPH Ethics Committee. The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study was approved by the Ethics Committee of the GDPH (No. GDREC2014122H). Informed consent was signed by each patient before study.
: The authors declare no competing interests.